Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rotavirus entry into intestinal epithelial cells (IECs) is a complex, multi-step process involving several cell surface molecules acting as attachment factors and co-receptors [1]. Initial attachment often involves the interaction of the viral spike protein VP4 (specifically the VP8* domain) with sialic acids or histo-blood group antigens (HBGAs) such as Lewis or H-type antigens, which vary based on the host's genetic secretor status [1, 2]. Subsequent steps involve interactions with integrins (e.g., alpha-v-beta-3, alpha-2-beta-1) and the heat shock cognate protein 70 (Hsc70) to facilitate viral internalization via endocytosis [2]. Recently, Neuropilin-1 (NRP1) has also been identified as a critical host factor for rotavirus infection in human intestinal cells [3]. These factors are primarily expressed on the apical surface of mature enterocytes at the tips of the villi in the small intestine [1]. Targeting these entry factors or their interactions with viral proteins represents a potential therapeutic strategy to prevent or treat rotavirus-induced gastroenteritis, a leading cause of severe diarrhea in children worldwide [1, 2].
Inhibition of viral attachment to host cell surface glycans and proteins, and blockade of subsequent endocytosis or membrane penetration pathways.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus entry factors.